Clinical Trial Update: Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This document reports results from Phase 1 and Phase 2 trials of a monoclonal antibody in combination with interleukin-2 in patients with leukemia or lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• Interleukin-2 (interleukin-2)
• Monoclonal antibody

Snippet

Sponsor: Roger Williams Medical Center | Conditions: Leukemia, Lymphoma | Phase 1, Phase 2 | Status: COMPLETED